Malignant Pleural Mesothelioma

• CLINICAL_TRIALS withdrawal · 2018-07-03
  Clinical Trial Update: Cryotherapy in Treating Patients With Lung Cancer That Has Spread to the Other Lung or Parts of the Body [NA]

  A Wake Forest University Health Sciences-sponsored clinical trial evaluating cryotherapy for metastatic lung cancer has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2018-05-14
  Clinical Trial Update: A Phase Ib Trial of a Maintenance Multipeptide Vaccine (S-588210) in Patients With Unresectable Malignant Pleural Mesothelioma Without Progression After First-Line Chemotherapy [Phase 1]

  The trial investigating maintenance multipeptide vaccine S-588210 in unresectable malignant pleural mesothelioma after first-line chemothera…

• CLINICAL_TRIALS withdrawal · 2016-12-07
  Clinical Trial Update: Concurrent Pemetrexed/Cisplatin With Pleural Intensity Modulated Radiation Therapy for Patients With Unresectable Malignant Pleural Mesothelioma [Phase 1]

  The Phase 1 trial evaluating concurrent pemetrexed/cisplatin with pleural intensity-modulated radiation therapy for unresectable malignant p…

• CLINICAL_TRIALS withdrawal · 2013-08-02
  Clinical Trial Update: AMG 102, Pemetrexed Disodium, and Cisplatin in Treating Patients With Malignant Pleural Mesothelioma [Phase 2]

  Phase 2 trial evaluating AMG 102 in combination with pemetrexed disodium and cisplatin for malignant pleural mesothelioma has been withdrawn…

• CLINICAL_TRIALS withdrawal · 2012-03-22
  Clinical Trial Update: A Phase I/II Study of First Line Vorinostat With Pemetrexed-cisplatin, in Patients With Malignant Pleural Mesothelioma [Phase 1, Phase 2]

  This clinical trial update reports the withdrawal of a Phase I/II study evaluating vorinostat added to pemetrexed-cisplatin as first-line th…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.